Company Filing History:
2 out of 123 
2 out of 262 Years Active: 2023-2024
Title: Innovations of Aaron Michael Dumas
Introduction
Aaron Michael Dumas is a notable inventor based in Stevenage, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of isoindolinone derivatives. With a total of two patents to his name, Dumas has demonstrated a commitment to advancing medical science.
Latest Patents
Dumas's latest patents include the invention titled "Isoindolinone inhibitors of the MDM2-P53 interaction and process for making them." This invention focuses on processes for preparing isoindolin-1-one derivatives, specifically the compound (2S,3S)-3-(4-chlorophenyl)-3-[(1R)-1-(4-chlorophenyl)-7-fluoro-5-[(1S)-1-hydroxy-1-(oxan-4-yl)propyl]-1-methoxy-3-oxo-2,3-dihydro-1H-isoindol-2-yl]-2-methylpropanoic acid. The patent also covers crystalline forms of this compound and its salts, showcasing Dumas's innovative approach to drug development.
Career Highlights
Throughout his career, Dumas has worked with reputable organizations such as Astex Therapeutics Limited and Cancer Research Technology Limited. His work in these companies has allowed him to contribute to important research and development projects in the pharmaceutical industry.
Collaborations
Dumas has collaborated with notable colleagues, including Steven Howard and Jeffrey David St Denis. These partnerships have likely enhanced his research efforts and contributed to the success of his inventions.
Conclusion
Aaron Michael Dumas is a distinguished inventor whose work in isoindolinone derivatives has the potential to impact the pharmaceutical industry significantly. His patents reflect a deep understanding of medicinal chemistry and a dedication to innovation.